Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Zettler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The FEBS Journal|February 4, 2010
Biochemical evidence for conformational changes in the cross-talk between adenylation and peptidyl-carrier protein domains of nonribosomal peptide synthetasesJoachim Zettler, Henning D Mootz
Angewandte Chemie (International Ed. in English)|March 9, 2011
Photocontrol of protein activity mediated by the cleavage reaction of a split inteinJens Binschik, Joachim Zettler, Henning D Mootz
FEBS Letters|March 24, 2009
The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reactionJoachim Zettler, Vivien Schütz, Henning D Mootz
Methods in Enzymology|July 28, 2009
Semisynthesis of proteins using split inteinsChristina Ludwig, Dirk Schwarzer, Joachim Zettler, et al.
Plos One|September 12, 2013
SPLICEFINDER - a fast and easy screening method for active protein trans-splicing positionsJoachim Zettler, Simone Eppmann, Alena Busche, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2019
TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal DysplasiasVibeke Miller Breinholt, Caroline E Rasmussen, Per Holse Mygind, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 11, 2019
Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for HypoparathyroidismLars Holten-Andersen, Susanne Pihl, Caroline E Rasmussen, et al.
Cancer Cell International|September 19, 2022
Intratumoral delivery of TransCon<sup>™</sup> TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine inductionLuis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, et al.
Journal for Immunotherapy of Cancer|July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancerDavid B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The FEBS Journal|February 4, 2010
Biochemical evidence for conformational changes in the cross-talk between adenylation and peptidyl-carrier protein domains of nonribosomal peptide synthetasesJoachim Zettler, Henning D Mootz
Angewandte Chemie (International Ed. in English)|March 9, 2011
Photocontrol of protein activity mediated by the cleavage reaction of a split inteinJens Binschik, Joachim Zettler, Henning D Mootz
FEBS Letters|March 24, 2009
The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reactionJoachim Zettler, Vivien Schütz, Henning D Mootz
Methods in Enzymology|July 28, 2009
Semisynthesis of proteins using split inteinsChristina Ludwig, Dirk Schwarzer, Joachim Zettler, et al.
Plos One|September 12, 2013
SPLICEFINDER - a fast and easy screening method for active protein trans-splicing positionsJoachim Zettler, Simone Eppmann, Alena Busche, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2019
TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal DysplasiasVibeke Miller Breinholt, Caroline E Rasmussen, Per Holse Mygind, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 11, 2019
Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for HypoparathyroidismLars Holten-Andersen, Susanne Pihl, Caroline E Rasmussen, et al.
Cancer Cell International|September 19, 2022
Intratumoral delivery of TransCon<sup>™</sup> TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine inductionLuis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, et al.
Journal for Immunotherapy of Cancer|July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancerDavid B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Pageof 1